DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Online

Technology In Clinical Trials-A New Pragmatism Emerging With Patient At The Core

概览

Parexel is at the forefront of change. We make studies more accessible by deploying our virtual trials service to reduce the practical, financial and geographical barriers to participation, thereby achieving better recruitment and retention.

Decentralized Clinical Trials – also called virtual/remote/siteless trials (Ph I-III) or direct-to-patient (DTP) /direct-with-patient (DWP) studies (Ph IV) – are designed to make it as easy as possible for patients to participate in clinical research by taking all or part of the study to them in their homes or local community.

精选主题

Technology in Clinical Trials- A new pragmatism emerging with patient at the core.

谁应该参加?

Professionals who work in the area of:

  • Biotechnology
  • Clinical Data Management/eClinical
  • Clinical Laboratory Data
  • Clinical Research
  • Clinical Safety and Pharmacovigilance
  • Clinical Supplies
  • Clinical Trial Management
  • Document Management/eSubmissions
  • Good Clinical Practice (GCP)
  • Patient Engagement
  • Pharmacoepidemiology/Quality of life/Health)
  • Pharmacology
  • Rare, Orphan Diseases
  • Research & Develop/Strategic Issues
  • Study Endpoints/Clinical Outcomes

学习目标

  • Why are Decentralized Clinical Trials (DCT) important?
  • Why Parexel’s Decentralized Clinical Trials are different?
  • How we are driving innovation through partnering?
  • 获得信息并保持参与

    不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。